Traditional Chinese medicinal composition for treating rectal cancer

Abstract

The invention discloses a traditional Chinese medicinal composition for treating rectal cancer. The traditional Chinese medicinal composition comprises, by weight, 10-30 parts of Oldenlandia Diffusa, 10-20 parts of Morinda Officinalis, 5-15 parts of Sanguisorba Officinalis, 10-20 parts of Cortex Phellodendri, 10-20 parts of Scutellaria Barbata, 10-20 parts of Pseudobulbus Cremastrae Seu Pleiones, 5-15 parts of pangolins, 10-20 parts of Eleutherococcus Senticosus, 10-20 parts of seaweed, 10-20 parts of Herba Pteridis Multifidae, 5-15 parts of Lucid Ganoderma, 10-20 parts of Peristrophe Japonica, 10-20 parts of Sargent Gloryvine, 10-20 parts of coix seeds, 5-15 parts of Flos Sophorae, 10-20 parts of Rheum Officinale, 10-20 parts of Selaginella Doederleinii, 10-20 parts of Oxalis Corymbosa, 5-15 parts of Radix Ranunculi Ternati, 10-20 parts of Salvia Chinensis and 10-20 parts of Hericium Erinaceus. The traditional Chinese medicinal composition has the advantages of the effect of strengthening body resistance, tonifying spleen, nourishing stomach, clearing away heat and toxic materials, promoting blood circulation and removing stasis, reliable curative effect and capabilities of effectively improving body immunity and reducing recurrence and metastasis.

Description

technical field [0001] The invention relates to a medical preparation of undetermined structure of traditional herbal medicine, especially a traditional Chinese medicine composition for treating rectal cancer. Background technique [0002] Rectal cancer refers to cancer between the dentate line and the rectosigmoid junction, and is one of the most common malignant tumors of the digestive tract. Rectal cancer is located in a low position and is easily diagnosed by digital rectal examination and sigmoidoscopy. However, because of its deep location in the pelvis, the anatomical relationship is complicated, the operation is not easy to complete, and the recurrence rate after surgery is high. The etiology of rectal cancer is still not very clear, and its incidence is related to social environment, eating habits, genetic factors and so on. The median age of onset of rectal cancer in my country is about 45 years old, and the incidence rate among young people tends to increase. At...

AI Technical Summary

Problems solved by technology

At present, the clinical treatment of rectal cancer is mainly based on surgical treatment, supplemented by postoperative chemotherapy and radiotherapy combined therapy, which has a certain effect, but some patients cannot accept surgery or chemotherapy, and some advanced patients cannot tolerate radiotherapy and chemotherapy. Many patients relapsed after radiotherapy and chemotherapy, resulting in poor quality of life for patients